ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bullish•SK Biopharmaceuticals
•02 Jul 2020 00:03

Do What the Locals Do - BUY Celltrion/Samsung Bio/SK Holdings on SK Biopharma Listing

Local institutions in Korea will have a significant underperformance on SK Biopharm listing and will clamor to buy and makeup for their...

Logo
502 Views
Share
bearish•Quantitative Analysis
•07 Jun 2020 09:58

Asia Short Interest Weekly - Massive Short Increase on Meituan, Geely

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
506 Views
Share
bullish•Celltrion Healthcare
•27 May 2020 03:25

Celltrion H Block Deal: Terms, Overhang, Arb Yield, & Post-Deal Trade Angle

Terms & overhangHere is another deal by OEP on Celltrion Healthcare. 4M shares are on the table (2.64% of the SO). The seller set the discount...

Logo
478 Views
Share
bullish•Celltrion Healthcare
•26 May 2020 17:37

A Block Deal Placement (348 Billion Won) Of Celltrion Healthcare by One Equity Partners

After the market close today, it was announced that One Equity Partners private equity firm will sell 348 billion won worth of Celltrion Healthcare...

Logo
545 Views
Share
bullish•Celltrion Healthcare
•26 May 2020 16:56

Celltrion Healthcare Placement: Past Performance Bodes Well for Sell-Down Before Lockup Expiry

One Equity Partners is looking to sell 4 m shares in Celltrion Healthcare (091990 KS). Post-placement, One Equity Partners will still have about a...

Logo
503 Views
Share
x